<DOC>
	<DOCNO>NCT00421993</DOCNO>
	<brief_summary>This multi-center , randomize , double-blind , parallel group study 12 week treatment acne vulgaris . Efficacy safety evaluation perform Screening ( safety ) , Baseline Weeks 1 , 2 , 4 , 8 12 . All Investigator 's Global Assessment evaluator lesion counter must train approve Galderma . The evaluator subject remain study . The primary objective demonstrate superiority efficacy assess safety Adapalene/Benzoyl Peroxide Topical Gel ( Adapalene/Benzoyl Peroxide Gel ) versus Adapalene Topical Gel , 0.1 % ( Adapalene Monad ) ; Benzoyl Peroxide Topical Gel , 2.5 % ( Benzoyl Peroxide Monad ) Topical Gel Vehicle ( Gel Vehicle ) treatment acne vulgaris 12 week .</brief_summary>
	<brief_title>A Study Demonstrate Efficacy Safety Adapalene/Benzoyl Peroxide Topical Gel Subjects With Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Adapalene</mesh_term>
	<mesh_term>Adapalene , Benzoyl Peroxide Drug Combination</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>A clinical diagnosis acne vulgaris facial involvement . A minimum 20 50 Inflammatory lesion A minimum 30 100 Noninflammatory lesion A score 3 ( Moderate ) Investigator 's Global Assessment Scale . More one acne nodule acne cyst . Acne conglobata , acne fulminans , secondary acne , severe acne . Known previous participation Adapalene/Benzoyl Peroxide Topical Gel Trial . Underlying disease require use interfering topical systemic therapy . Use prohibit medication prior study unless appropriate washout period document Use hormonal contraceptive solely control acne</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Acne vulgaris</keyword>
	<keyword>Adapalene</keyword>
	<keyword>Benzoyl Peroxide</keyword>
</DOC>